nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2A—myenteric nerve plexus—colon cancer	0.0219	0.215	CbGeAlD
Duloxetine—HTR2A—vein—colon cancer	0.0141	0.138	CbGeAlD
Duloxetine—NPY1R—renal system—colon cancer	0.0099	0.0972	CbGeAlD
Duloxetine—NPY1R—vagina—colon cancer	0.00717	0.0704	CbGeAlD
Duloxetine—NPY1R—liver—colon cancer	0.00605	0.0594	CbGeAlD
Duloxetine—HTR2A—endothelium—colon cancer	0.00485	0.0476	CbGeAlD
Duloxetine—NPY1R—lymph node—colon cancer	0.00464	0.0456	CbGeAlD
Duloxetine—HTR2A—blood vessel—colon cancer	0.00447	0.0439	CbGeAlD
Duloxetine—SLC6A4—digestive system—colon cancer	0.00313	0.0307	CbGeAlD
Duloxetine—HTR2A—embryo—colon cancer	0.00267	0.0262	CbGeAlD
Duloxetine—CYP1A2—renal system—colon cancer	0.00258	0.0254	CbGeAlD
Duloxetine—HTR2A—epithelium—colon cancer	0.00218	0.0214	CbGeAlD
Duloxetine—Protriptyline—ABCB1—colon cancer	0.00217	0.476	CrCbGaD
Duloxetine—CYP1A2—digestive system—colon cancer	0.00212	0.0208	CbGeAlD
Duloxetine—HTR2A—smooth muscle tissue—colon cancer	0.0021	0.0206	CbGeAlD
Duloxetine—HTR2A—renal system—colon cancer	0.00202	0.0198	CbGeAlD
Duloxetine—CYP2D6—renal system—colon cancer	0.00184	0.0181	CbGeAlD
Duloxetine—HTR2A—digestive system—colon cancer	0.00166	0.0163	CbGeAlD
Duloxetine—CYP1A2—liver—colon cancer	0.00158	0.0155	CbGeAlD
Duloxetine—SLC6A2—lymph node—colon cancer	0.00157	0.0155	CbGeAlD
Duloxetine—CYP2D6—digestive system—colon cancer	0.00151	0.0148	CbGeAlD
Duloxetine—Fluoxetine—ABCB1—colon cancer	0.00148	0.325	CrCbGaD
Duloxetine—HTR2A—vagina—colon cancer	0.00146	0.0144	CbGeAlD
Duloxetine—Anaphylactic shock—Irinotecan—colon cancer	0.00137	0.00154	CcSEcCtD
Duloxetine—Chest pain—Fluorouracil—colon cancer	0.00137	0.00153	CcSEcCtD
Duloxetine—Myalgia—Fluorouracil—colon cancer	0.00137	0.00153	CcSEcCtD
Duloxetine—Infection—Irinotecan—colon cancer	0.00136	0.00153	CcSEcCtD
Duloxetine—Hyperhidrosis—Vincristine—colon cancer	0.00136	0.00152	CcSEcCtD
Duloxetine—Hepatobiliary disease—Capecitabine—colon cancer	0.00136	0.00152	CcSEcCtD
Duloxetine—Epistaxis—Capecitabine—colon cancer	0.00136	0.00152	CcSEcCtD
Duloxetine—Discomfort—Fluorouracil—colon cancer	0.00135	0.00152	CcSEcCtD
Duloxetine—Shock—Irinotecan—colon cancer	0.00135	0.00151	CcSEcCtD
Duloxetine—Nervous system disorder—Irinotecan—colon cancer	0.00135	0.00151	CcSEcCtD
Duloxetine—Thrombocytopenia—Irinotecan—colon cancer	0.00134	0.0015	CcSEcCtD
Duloxetine—Anorexia—Vincristine—colon cancer	0.00134	0.0015	CcSEcCtD
Duloxetine—Irritability—Methotrexate—colon cancer	0.00133	0.00149	CcSEcCtD
Duloxetine—Hyperhidrosis—Irinotecan—colon cancer	0.00133	0.00148	CcSEcCtD
Duloxetine—Confusional state—Fluorouracil—colon cancer	0.00133	0.00148	CcSEcCtD
Duloxetine—Mood swings—Methotrexate—colon cancer	0.00132	0.00147	CcSEcCtD
Duloxetine—Anaphylactic shock—Fluorouracil—colon cancer	0.00131	0.00147	CcSEcCtD
Duloxetine—Oedema—Fluorouracil—colon cancer	0.00131	0.00147	CcSEcCtD
Duloxetine—Anorexia—Irinotecan—colon cancer	0.00131	0.00146	CcSEcCtD
Duloxetine—Ataxia—Methotrexate—colon cancer	0.00131	0.00146	CcSEcCtD
Duloxetine—Infection—Fluorouracil—colon cancer	0.00131	0.00146	CcSEcCtD
Duloxetine—Haemoglobin—Capecitabine—colon cancer	0.0013	0.00145	CcSEcCtD
Duloxetine—Hepatitis—Capecitabine—colon cancer	0.00129	0.00145	CcSEcCtD
Duloxetine—Haemorrhage—Capecitabine—colon cancer	0.00129	0.00145	CcSEcCtD
Duloxetine—Nervous system disorder—Fluorouracil—colon cancer	0.00129	0.00144	CcSEcCtD
Duloxetine—Thrombocytopenia—Fluorouracil—colon cancer	0.00129	0.00144	CcSEcCtD
Duloxetine—Hypoaesthesia—Capecitabine—colon cancer	0.00129	0.00144	CcSEcCtD
Duloxetine—Liver function test abnormal—Methotrexate—colon cancer	0.00128	0.00144	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00128	0.00144	CcSEcCtD
Duloxetine—Pharyngitis—Capecitabine—colon cancer	0.00128	0.00144	CcSEcCtD
Duloxetine—Tachycardia—Fluorouracil—colon cancer	0.00128	0.00144	CcSEcCtD
Duloxetine—Urinary tract disorder—Capecitabine—colon cancer	0.00128	0.00143	CcSEcCtD
Duloxetine—Insomnia—Vincristine—colon cancer	0.00127	0.00143	CcSEcCtD
Duloxetine—Oedema peripheral—Capecitabine—colon cancer	0.00127	0.00143	CcSEcCtD
Duloxetine—Connective tissue disorder—Capecitabine—colon cancer	0.00127	0.00142	CcSEcCtD
Duloxetine—Urethral disorder—Capecitabine—colon cancer	0.00127	0.00142	CcSEcCtD
Duloxetine—Paraesthesia—Vincristine—colon cancer	0.00127	0.00142	CcSEcCtD
Duloxetine—Breast disorder—Methotrexate—colon cancer	0.00126	0.00141	CcSEcCtD
Duloxetine—Anorexia—Fluorouracil—colon cancer	0.00125	0.0014	CcSEcCtD
Duloxetine—Visual impairment—Capecitabine—colon cancer	0.00125	0.00139	CcSEcCtD
Duloxetine—Insomnia—Irinotecan—colon cancer	0.00124	0.00139	CcSEcCtD
Duloxetine—HTR2A—liver—colon cancer	0.00123	0.0121	CbGeAlD
Duloxetine—Paraesthesia—Irinotecan—colon cancer	0.00123	0.00138	CcSEcCtD
Duloxetine—Decreased appetite—Vincristine—colon cancer	0.00123	0.00137	CcSEcCtD
Duloxetine—Erythema multiforme—Capecitabine—colon cancer	0.00122	0.00137	CcSEcCtD
Duloxetine—Somnolence—Irinotecan—colon cancer	0.00122	0.00137	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Vincristine—colon cancer	0.00122	0.00136	CcSEcCtD
Duloxetine—Fatigue—Vincristine—colon cancer	0.00122	0.00136	CcSEcCtD
Duloxetine—Eye disorder—Capecitabine—colon cancer	0.00121	0.00135	CcSEcCtD
Duloxetine—Dyspepsia—Irinotecan—colon cancer	0.00121	0.00135	CcSEcCtD
Duloxetine—Tinnitus—Capecitabine—colon cancer	0.00121	0.00135	CcSEcCtD
Duloxetine—Constipation—Vincristine—colon cancer	0.00121	0.00135	CcSEcCtD
Duloxetine—Pain—Vincristine—colon cancer	0.00121	0.00135	CcSEcCtD
Duloxetine—Flushing—Capecitabine—colon cancer	0.0012	0.00134	CcSEcCtD
Duloxetine—Cardiac disorder—Capecitabine—colon cancer	0.0012	0.00134	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0012	0.00134	CcSEcCtD
Duloxetine—Decreased appetite—Irinotecan—colon cancer	0.00119	0.00134	CcSEcCtD
Duloxetine—Insomnia—Fluorouracil—colon cancer	0.00119	0.00133	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00118	0.00133	CcSEcCtD
Duloxetine—Fatigue—Irinotecan—colon cancer	0.00118	0.00132	CcSEcCtD
Duloxetine—Paraesthesia—Fluorouracil—colon cancer	0.00118	0.00132	CcSEcCtD
Duloxetine—Pancreatitis—Methotrexate—colon cancer	0.00118	0.00132	CcSEcCtD
Duloxetine—Constipation—Irinotecan—colon cancer	0.00117	0.00131	CcSEcCtD
Duloxetine—Pain—Irinotecan—colon cancer	0.00117	0.00131	CcSEcCtD
Duloxetine—Angiopathy—Capecitabine—colon cancer	0.00117	0.00131	CcSEcCtD
Duloxetine—Somnolence—Fluorouracil—colon cancer	0.00117	0.00131	CcSEcCtD
Duloxetine—Immune system disorder—Capecitabine—colon cancer	0.00117	0.00131	CcSEcCtD
Duloxetine—Mediastinal disorder—Capecitabine—colon cancer	0.00117	0.0013	CcSEcCtD
Duloxetine—Chills—Capecitabine—colon cancer	0.00116	0.0013	CcSEcCtD
Duloxetine—Dyspepsia—Fluorouracil—colon cancer	0.00116	0.00129	CcSEcCtD
Duloxetine—Arrhythmia—Capecitabine—colon cancer	0.00116	0.00129	CcSEcCtD
Duloxetine—Abdominal discomfort—Methotrexate—colon cancer	0.00115	0.00129	CcSEcCtD
Duloxetine—Gastrointestinal pain—Vincristine—colon cancer	0.00115	0.00129	CcSEcCtD
Duloxetine—Decreased appetite—Fluorouracil—colon cancer	0.00114	0.00128	CcSEcCtD
Duloxetine—Alopecia—Capecitabine—colon cancer	0.00114	0.00128	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00113	0.00127	CcSEcCtD
Duloxetine—Mental disorder—Capecitabine—colon cancer	0.00113	0.00127	CcSEcCtD
Duloxetine—Feeling abnormal—Irinotecan—colon cancer	0.00113	0.00127	CcSEcCtD
Duloxetine—Erythema—Capecitabine—colon cancer	0.00113	0.00126	CcSEcCtD
Duloxetine—Malnutrition—Capecitabine—colon cancer	0.00113	0.00126	CcSEcCtD
Duloxetine—Dysuria—Methotrexate—colon cancer	0.00112	0.00126	CcSEcCtD
Duloxetine—CYP2D6—liver—colon cancer	0.00112	0.011	CbGeAlD
Duloxetine—Pain—Fluorouracil—colon cancer	0.00112	0.00126	CcSEcCtD
Duloxetine—Gastrointestinal pain—Irinotecan—colon cancer	0.00112	0.00126	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Methotrexate—colon cancer	0.00112	0.00125	CcSEcCtD
Duloxetine—Body temperature increased—Vincristine—colon cancer	0.00111	0.00125	CcSEcCtD
Duloxetine—Abdominal pain—Vincristine—colon cancer	0.00111	0.00125	CcSEcCtD
Duloxetine—Flatulence—Capecitabine—colon cancer	0.00111	0.00124	CcSEcCtD
Duloxetine—Erectile dysfunction—Methotrexate—colon cancer	0.00111	0.00124	CcSEcCtD
Duloxetine—Dysgeusia—Capecitabine—colon cancer	0.0011	0.00123	CcSEcCtD
Duloxetine—Photosensitivity reaction—Methotrexate—colon cancer	0.0011	0.00123	CcSEcCtD
Duloxetine—Back pain—Capecitabine—colon cancer	0.00109	0.00122	CcSEcCtD
Duloxetine—Abdominal pain—Irinotecan—colon cancer	0.00108	0.00121	CcSEcCtD
Duloxetine—Body temperature increased—Irinotecan—colon cancer	0.00108	0.00121	CcSEcCtD
Duloxetine—Feeling abnormal—Fluorouracil—colon cancer	0.00108	0.00121	CcSEcCtD
Duloxetine—Muscle spasms—Capecitabine—colon cancer	0.00108	0.00121	CcSEcCtD
Duloxetine—Infestation NOS—Methotrexate—colon cancer	0.00107	0.0012	CcSEcCtD
Duloxetine—Infestation—Methotrexate—colon cancer	0.00107	0.0012	CcSEcCtD
Duloxetine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00106	0.00119	CcSEcCtD
Duloxetine—Vision blurred—Capecitabine—colon cancer	0.00106	0.00119	CcSEcCtD
Duloxetine—Tremor—Capecitabine—colon cancer	0.00105	0.00118	CcSEcCtD
Duloxetine—Renal failure—Methotrexate—colon cancer	0.00105	0.00118	CcSEcCtD
Duloxetine—Stomatitis—Methotrexate—colon cancer	0.00105	0.00117	CcSEcCtD
Duloxetine—Ill-defined disorder—Capecitabine—colon cancer	0.00104	0.00117	CcSEcCtD
Duloxetine—Urticaria—Fluorouracil—colon cancer	0.00104	0.00117	CcSEcCtD
Duloxetine—Conjunctivitis—Methotrexate—colon cancer	0.00104	0.00117	CcSEcCtD
Duloxetine—Anaemia—Capecitabine—colon cancer	0.00104	0.00116	CcSEcCtD
Duloxetine—Body temperature increased—Fluorouracil—colon cancer	0.00104	0.00116	CcSEcCtD
Duloxetine—Hypersensitivity—Vincristine—colon cancer	0.00104	0.00116	CcSEcCtD
Duloxetine—Malaise—Capecitabine—colon cancer	0.00102	0.00114	CcSEcCtD
Duloxetine—Hepatobiliary disease—Methotrexate—colon cancer	0.00101	0.00113	CcSEcCtD
Duloxetine—Epistaxis—Methotrexate—colon cancer	0.00101	0.00113	CcSEcCtD
Duloxetine—Vertigo—Capecitabine—colon cancer	0.00101	0.00113	CcSEcCtD
Duloxetine—Hypersensitivity—Irinotecan—colon cancer	0.00101	0.00113	CcSEcCtD
Duloxetine—Asthenia—Vincristine—colon cancer	0.00101	0.00113	CcSEcCtD
Duloxetine—Syncope—Capecitabine—colon cancer	0.00101	0.00113	CcSEcCtD
Duloxetine—Leukopenia—Capecitabine—colon cancer	0.00101	0.00113	CcSEcCtD
Duloxetine—Palpitations—Capecitabine—colon cancer	0.000995	0.00111	CcSEcCtD
Duloxetine—Loss of consciousness—Capecitabine—colon cancer	0.000989	0.00111	CcSEcCtD
Duloxetine—Asthenia—Irinotecan—colon cancer	0.000985	0.0011	CcSEcCtD
Duloxetine—Cough—Capecitabine—colon cancer	0.000982	0.0011	CcSEcCtD
Duloxetine—Hypertension—Capecitabine—colon cancer	0.000972	0.00109	CcSEcCtD
Duloxetine—Hypersensitivity—Fluorouracil—colon cancer	0.000968	0.00108	CcSEcCtD
Duloxetine—Haemoglobin—Methotrexate—colon cancer	0.000967	0.00108	CcSEcCtD
Duloxetine—Diarrhoea—Vincristine—colon cancer	0.000964	0.00108	CcSEcCtD
Duloxetine—Hepatitis—Methotrexate—colon cancer	0.000963	0.00108	CcSEcCtD
Duloxetine—Haemorrhage—Methotrexate—colon cancer	0.000963	0.00108	CcSEcCtD
Duloxetine—Arthralgia—Capecitabine—colon cancer	0.000958	0.00107	CcSEcCtD
Duloxetine—Chest pain—Capecitabine—colon cancer	0.000958	0.00107	CcSEcCtD
Duloxetine—Myalgia—Capecitabine—colon cancer	0.000958	0.00107	CcSEcCtD
Duloxetine—Pharyngitis—Methotrexate—colon cancer	0.000955	0.00107	CcSEcCtD
Duloxetine—Anxiety—Capecitabine—colon cancer	0.000955	0.00107	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000952	0.00106	CcSEcCtD
Duloxetine—Urinary tract disorder—Methotrexate—colon cancer	0.000951	0.00106	CcSEcCtD
Duloxetine—Discomfort—Capecitabine—colon cancer	0.000947	0.00106	CcSEcCtD
Duloxetine—Urethral disorder—Methotrexate—colon cancer	0.000944	0.00106	CcSEcCtD
Duloxetine—Diarrhoea—Irinotecan—colon cancer	0.000939	0.00105	CcSEcCtD
Duloxetine—Dry mouth—Capecitabine—colon cancer	0.000937	0.00105	CcSEcCtD
Duloxetine—Dizziness—Vincristine—colon cancer	0.000932	0.00104	CcSEcCtD
Duloxetine—Pruritus—Fluorouracil—colon cancer	0.00093	0.00104	CcSEcCtD
Duloxetine—Visual impairment—Methotrexate—colon cancer	0.000928	0.00104	CcSEcCtD
Duloxetine—Confusional state—Capecitabine—colon cancer	0.000926	0.00104	CcSEcCtD
Duloxetine—Oedema—Capecitabine—colon cancer	0.000919	0.00103	CcSEcCtD
Duloxetine—Infection—Capecitabine—colon cancer	0.000913	0.00102	CcSEcCtD
Duloxetine—Erythema multiforme—Methotrexate—colon cancer	0.00091	0.00102	CcSEcCtD
Duloxetine—Dizziness—Irinotecan—colon cancer	0.000908	0.00102	CcSEcCtD
Duloxetine—Propranolol—ABCB1—colon cancer	0.000905	0.199	CrCbGaD
Duloxetine—Shock—Capecitabine—colon cancer	0.000904	0.00101	CcSEcCtD
Duloxetine—Nervous system disorder—Capecitabine—colon cancer	0.000901	0.00101	CcSEcCtD
Duloxetine—Eye disorder—Methotrexate—colon cancer	0.0009	0.00101	CcSEcCtD
Duloxetine—Diarrhoea—Fluorouracil—colon cancer	0.000899	0.00101	CcSEcCtD
Duloxetine—Thrombocytopenia—Capecitabine—colon cancer	0.000899	0.00101	CcSEcCtD
Duloxetine—Tinnitus—Methotrexate—colon cancer	0.000897	0.001	CcSEcCtD
Duloxetine—Tachycardia—Capecitabine—colon cancer	0.000897	0.001	CcSEcCtD
Duloxetine—Vomiting—Vincristine—colon cancer	0.000896	0.001	CcSEcCtD
Duloxetine—Cardiac disorder—Methotrexate—colon cancer	0.000893	0.001	CcSEcCtD
Duloxetine—Skin disorder—Capecitabine—colon cancer	0.000892	0.000998	CcSEcCtD
Duloxetine—Rash—Vincristine—colon cancer	0.000889	0.000994	CcSEcCtD
Duloxetine—Hyperhidrosis—Capecitabine—colon cancer	0.000888	0.000994	CcSEcCtD
Duloxetine—Dermatitis—Vincristine—colon cancer	0.000888	0.000993	CcSEcCtD
Duloxetine—Headache—Vincristine—colon cancer	0.000883	0.000988	CcSEcCtD
Duloxetine—Anorexia—Capecitabine—colon cancer	0.000876	0.00098	CcSEcCtD
Duloxetine—Angiopathy—Methotrexate—colon cancer	0.000873	0.000977	CcSEcCtD
Duloxetine—Vomiting—Irinotecan—colon cancer	0.000873	0.000977	CcSEcCtD
Duloxetine—Immune system disorder—Methotrexate—colon cancer	0.000869	0.000973	CcSEcCtD
Duloxetine—Dizziness—Fluorouracil—colon cancer	0.000869	0.000973	CcSEcCtD
Duloxetine—Mediastinal disorder—Methotrexate—colon cancer	0.000867	0.000971	CcSEcCtD
Duloxetine—Rash—Irinotecan—colon cancer	0.000865	0.000968	CcSEcCtD
Duloxetine—Dermatitis—Irinotecan—colon cancer	0.000865	0.000968	CcSEcCtD
Duloxetine—Chills—Methotrexate—colon cancer	0.000864	0.000966	CcSEcCtD
Duloxetine—Headache—Irinotecan—colon cancer	0.00086	0.000962	CcSEcCtD
Duloxetine—Alopecia—Methotrexate—colon cancer	0.000851	0.000952	CcSEcCtD
Duloxetine—Mental disorder—Methotrexate—colon cancer	0.000843	0.000944	CcSEcCtD
Duloxetine—Erythema—Methotrexate—colon cancer	0.000838	0.000938	CcSEcCtD
Duloxetine—Malnutrition—Methotrexate—colon cancer	0.000838	0.000938	CcSEcCtD
Duloxetine—Nausea—Vincristine—colon cancer	0.000837	0.000937	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000837	0.000937	CcSEcCtD
Duloxetine—Vomiting—Fluorouracil—colon cancer	0.000836	0.000935	CcSEcCtD
Duloxetine—Insomnia—Capecitabine—colon cancer	0.000831	0.00093	CcSEcCtD
Duloxetine—Rash—Fluorouracil—colon cancer	0.000829	0.000927	CcSEcCtD
Duloxetine—Dermatitis—Fluorouracil—colon cancer	0.000828	0.000927	CcSEcCtD
Duloxetine—Paraesthesia—Capecitabine—colon cancer	0.000825	0.000923	CcSEcCtD
Duloxetine—Headache—Fluorouracil—colon cancer	0.000824	0.000922	CcSEcCtD
Duloxetine—Dysgeusia—Methotrexate—colon cancer	0.000821	0.000918	CcSEcCtD
Duloxetine—Nausea—Irinotecan—colon cancer	0.000815	0.000912	CcSEcCtD
Duloxetine—Back pain—Methotrexate—colon cancer	0.00081	0.000907	CcSEcCtD
Duloxetine—Dyspepsia—Capecitabine—colon cancer	0.000809	0.000905	CcSEcCtD
Duloxetine—Decreased appetite—Capecitabine—colon cancer	0.000799	0.000894	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000793	0.000887	CcSEcCtD
Duloxetine—Fatigue—Capecitabine—colon cancer	0.000792	0.000886	CcSEcCtD
Duloxetine—Vision blurred—Methotrexate—colon cancer	0.00079	0.000884	CcSEcCtD
Duloxetine—Constipation—Capecitabine—colon cancer	0.000786	0.000879	CcSEcCtD
Duloxetine—Pain—Capecitabine—colon cancer	0.000786	0.000879	CcSEcCtD
Duloxetine—Nausea—Fluorouracil—colon cancer	0.000781	0.000874	CcSEcCtD
Duloxetine—Ill-defined disorder—Methotrexate—colon cancer	0.000777	0.00087	CcSEcCtD
Duloxetine—Anaemia—Methotrexate—colon cancer	0.000774	0.000867	CcSEcCtD
Duloxetine—Feeling abnormal—Capecitabine—colon cancer	0.000757	0.000847	CcSEcCtD
Duloxetine—Malaise—Methotrexate—colon cancer	0.000756	0.000846	CcSEcCtD
Duloxetine—Vertigo—Methotrexate—colon cancer	0.000753	0.000842	CcSEcCtD
Duloxetine—Gastrointestinal pain—Capecitabine—colon cancer	0.000751	0.000841	CcSEcCtD
Duloxetine—Leukopenia—Methotrexate—colon cancer	0.00075	0.000839	CcSEcCtD
Duloxetine—Cough—Methotrexate—colon cancer	0.000731	0.000818	CcSEcCtD
Duloxetine—Urticaria—Capecitabine—colon cancer	0.00073	0.000817	CcSEcCtD
Duloxetine—Body temperature increased—Capecitabine—colon cancer	0.000726	0.000813	CcSEcCtD
Duloxetine—Abdominal pain—Capecitabine—colon cancer	0.000726	0.000813	CcSEcCtD
Duloxetine—Convulsion—Methotrexate—colon cancer	0.000726	0.000812	CcSEcCtD
Duloxetine—Arthralgia—Methotrexate—colon cancer	0.000713	0.000798	CcSEcCtD
Duloxetine—Chest pain—Methotrexate—colon cancer	0.000713	0.000798	CcSEcCtD
Duloxetine—Myalgia—Methotrexate—colon cancer	0.000713	0.000798	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000708	0.000793	CcSEcCtD
Duloxetine—Discomfort—Methotrexate—colon cancer	0.000705	0.000789	CcSEcCtD
Duloxetine—Confusional state—Methotrexate—colon cancer	0.00069	0.000772	CcSEcCtD
Duloxetine—Anaphylactic shock—Methotrexate—colon cancer	0.000684	0.000765	CcSEcCtD
Duloxetine—Infection—Methotrexate—colon cancer	0.000679	0.00076	CcSEcCtD
Duloxetine—Hypersensitivity—Capecitabine—colon cancer	0.000677	0.000757	CcSEcCtD
Duloxetine—Nervous system disorder—Methotrexate—colon cancer	0.000671	0.00075	CcSEcCtD
Duloxetine—Thrombocytopenia—Methotrexate—colon cancer	0.00067	0.000749	CcSEcCtD
Duloxetine—Skin disorder—Methotrexate—colon cancer	0.000664	0.000743	CcSEcCtD
Duloxetine—Hyperhidrosis—Methotrexate—colon cancer	0.000661	0.00074	CcSEcCtD
Duloxetine—Asthenia—Capecitabine—colon cancer	0.000659	0.000738	CcSEcCtD
Duloxetine—Anorexia—Methotrexate—colon cancer	0.000652	0.000729	CcSEcCtD
Duloxetine—Pruritus—Capecitabine—colon cancer	0.00065	0.000727	CcSEcCtD
Duloxetine—Diarrhoea—Capecitabine—colon cancer	0.000629	0.000703	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000623	0.000697	CcSEcCtD
Duloxetine—Insomnia—Methotrexate—colon cancer	0.000618	0.000692	CcSEcCtD
Duloxetine—Paraesthesia—Methotrexate—colon cancer	0.000614	0.000687	CcSEcCtD
Duloxetine—Somnolence—Methotrexate—colon cancer	0.000608	0.00068	CcSEcCtD
Duloxetine—Dizziness—Capecitabine—colon cancer	0.000607	0.00068	CcSEcCtD
Duloxetine—Dyspepsia—Methotrexate—colon cancer	0.000602	0.000674	CcSEcCtD
Duloxetine—Decreased appetite—Methotrexate—colon cancer	0.000594	0.000665	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00059	0.000661	CcSEcCtD
Duloxetine—Fatigue—Methotrexate—colon cancer	0.00059	0.00066	CcSEcCtD
Duloxetine—Pain—Methotrexate—colon cancer	0.000585	0.000654	CcSEcCtD
Duloxetine—Vomiting—Capecitabine—colon cancer	0.000584	0.000654	CcSEcCtD
Duloxetine—Rash—Capecitabine—colon cancer	0.000579	0.000648	CcSEcCtD
Duloxetine—Dermatitis—Capecitabine—colon cancer	0.000579	0.000648	CcSEcCtD
Duloxetine—Headache—Capecitabine—colon cancer	0.000575	0.000644	CcSEcCtD
Duloxetine—Feeling abnormal—Methotrexate—colon cancer	0.000564	0.000631	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methotrexate—colon cancer	0.000559	0.000626	CcSEcCtD
Duloxetine—Nausea—Capecitabine—colon cancer	0.000546	0.000611	CcSEcCtD
Duloxetine—Urticaria—Methotrexate—colon cancer	0.000543	0.000608	CcSEcCtD
Duloxetine—Body temperature increased—Methotrexate—colon cancer	0.000541	0.000605	CcSEcCtD
Duloxetine—Abdominal pain—Methotrexate—colon cancer	0.000541	0.000605	CcSEcCtD
Duloxetine—Hypersensitivity—Methotrexate—colon cancer	0.000504	0.000564	CcSEcCtD
Duloxetine—Asthenia—Methotrexate—colon cancer	0.000491	0.000549	CcSEcCtD
Duloxetine—Pruritus—Methotrexate—colon cancer	0.000484	0.000541	CcSEcCtD
Duloxetine—Diarrhoea—Methotrexate—colon cancer	0.000468	0.000524	CcSEcCtD
Duloxetine—Dizziness—Methotrexate—colon cancer	0.000452	0.000506	CcSEcCtD
Duloxetine—Vomiting—Methotrexate—colon cancer	0.000435	0.000487	CcSEcCtD
Duloxetine—Rash—Methotrexate—colon cancer	0.000431	0.000482	CcSEcCtD
Duloxetine—Dermatitis—Methotrexate—colon cancer	0.000431	0.000482	CcSEcCtD
Duloxetine—Headache—Methotrexate—colon cancer	0.000428	0.000479	CcSEcCtD
Duloxetine—Nausea—Methotrexate—colon cancer	0.000406	0.000455	CcSEcCtD
